Could an Emerging AI Platform Supplant Traditional MRI for Assessing Prostate Cancer?

The Food and Drug Administration has granted 510(k) clearance to iQuest (Avenda Health), an artificial intelligence (AI) platform that combines findings from magnetic resonance imaging (MRI), pathology reports and biopsy results to facilitate three-dimensional mapping of prostate cancer.

FDA Clears AI-Powered Echocardiography Platform for Detecting Heart Failure with Preserved Ejection Fraction

The EchoGo® Heart Failure device reportedly has an 87.8 percent sensitivity rate and an 83 percent specificity rate for diagnosing heart failure with preserved ejection fraction, an increasingly prevalent but frequently misdiagnosed condition.

New AI Modality Gets FDA Nod for Detecting Aortic Atherosclerosis and Ectasia on Chest X-Rays

One study showed use of the Aorta-CAD cloud-based software led to a 62 percent reduction of missed aortic calcification that suggested aortic atherosclerosis.